Abstract
Introduction
Cyclophotocoagulation is an effective form of therapy to reduce intraocular pressure. [1] [2] [3] This pressure lowering effect is achieved by thermal ablation of the ciliary body, 4, 5 causing reduced aqueous production. Using a standardised treatment protocol and a diode laser, cyclophotocoagulation (cyclodiode therapy) produces intraocular pressure reduction with relatively few complications. 6 Many reports on this therapy utilise a special probe called the 'G-probe' (Iris Medical Instruments Inc., Mountain View, CA, USA) and an infrared diode laser (810 nm) (Oculight SLx, Iris Medical Instruments Inc., Mountain View, CA, USA). [6] [7] [8] [9] It is recommended that each probe should only be used once for one session of laser treatment. 10 However, many surgeons reuse individual G-probes (PA Bloom, 1999, personal communication) , despite knowing the risks associated with reusing a single-use device. 11 To what extent surgeons reuse the probes is not known. It is likely that with reuse, there is a gradual reduction of laser output of the G-probe resulting in reduced effectiveness of ciliary body ablation. 10 However, it is technically difficult to measure the direct laser output of the G-probe in a clinical setting. 13, 14 We assessed the proportion of clinicians reusing the Gprobe after sending a questionnaire to ophthalmologists to whom an Iris Medical Diode Laser was supplied. In a separate study, we developed a new method to assess the output from the G-probe using a custom-made grey scale chart. The method was found to be quick, simple to perform, and highly reproducible, providing information on the output of old and new probes.
Materials and methods
Three separate studies were conducted and are described under the following categories:
(A) A questionnaire-based survey of ophthalmologists aimed to investigate the current use of the G-probe. (B) A pilot study aimed to assess a method to test the output of the G-probe using a custom-made grey scale chart. (C) Using the developed grey scale chart test, a study was performed to assess the effect of different laser settings to produce laser burns on the grey scale chart test. Several copies of the chart were printed on to white paper (paper density 80 g/m), using an inkjet printer (Hewlett-Packard 720c, San Diego, USA) ( Figure 1 ). Each Figure 1 Custom-made grey scale chart used in the study; the above image shows that the chart contains a palette of grey shade blocks of increasing grey densities.
shade of grey on the palette was graded for grey density by comparing it to a standard grey scale (Kodak Control Grey Scale 14, Eastman Kodak Company, Rochester, NY, USA). Some consecutive grey shades showed similar densities to each other and when this occurred, one of the shades was excluded. A final number of differing 12 grey shades was found. All comparisons were performed by three independent observers who assigned a number to each grey shade. The value of each assigned number corresponded to the Kodak Control Grey Scale and ranged from 1 to 12 with increasing order of grey density.
Design of probe holder A probe holder was produced from black plastic by the Mechanical Engineering Department, Nottingham University (Figure 2a ) (available from Mr S Vernon, Department of Ophthalmology, Queens Medical Centre, Nottingham, UK). An inner aperture in the holder permitted the Gprobe to be held vertical to the plane of the holder. The design ensured that when the leading edge of the probe reached the lower flat surface of the holder, the distance between the probe tip and the grey scale was constant and was kept at a distance of 2 mm. This arrangement is shown in Figure 2b .
Producing a 'test' burn To produce a burn the following protocol was followed: The tip of the G-probe was cleaned with isopropyl alcohol swab (Sterets, Seaton Healthcare Group, Oldham, UK) and allowed to dry in air. Holding the G-probe vertically, the probe was inserted into the inner aperture of the holder so that the leading edge of the probe reached the lower flat surface of the holder. The whole arrangement of the probe and holder was placed over the grey scale sheet so that the probe position coincided over a selected grey shade. With both the holder and G-probe held firmly over the grey scale sheet, the laser was then fired in an attempt to produce a burn on the sheet.
Determining 'threshold burns' at 'standard settings' A new G-probe was used in the pilot study. The diode laser was set at the 'standard settings' for energy exposure used in our unit for cyclodiode treatment (2000 mW, 2000 ms). 6 Three burns were attempted on each grey shade on the grey scale chart. The test was repeated on different charts (printed on different batches of paper) to check for interchart variations. The test was also repeated by different operators to check for inter-and intraoperator variations; after each shot, the probe tip was cleaned with isopropyl alcohol swab. The exposed charts were examined under a dissecting microscope (Nikon, Kingston-upon-Thames, UK). Burns were identified by any discoloration at the site of laser application (Figure 2c ), and using a microscope graticule (Graticules, Hamblin, UK) the diameter of each burn was measured. Measurements of the three attempted burns for each grey shade were averaged and expressed as the 'burn size' in micrometres7standard deviation (mm7SD).
After this initial assessment, a further five new probes were tested on different sheets and by different operators to assess the inter-intra-probe, intersheet and intra-interoperator variations of the technique. The five probes were then used to determine the laser power setting that produced 'threshold' burns. This was done by testing each probe on a modified sheet containing only blocks of grey shade 8. Then each probe was tested using laser power output settings from 1000 to 2100 mW, increasing by 100 mW steps. Throughout this assessment the time setting was kept constant at 2000 ms and after each shot, the probe tip was cleaned with isopropyl alcohol. After completing these assessments, the sheets were analysed for the burns produced as described earlier.
Study C: using the 'grey scale test' to assess the output of the G-probe using different laser settings Assessing changing laser output parameters The effect of changing output parameters was then assessed. Using the burn protocol in the pilot study, three separate burns were attempted on each grey shade on the grey scale palette. Measurements of the burn size and burn score were made. The burning effect of the G-probe was assessed at power settings of 1000, 1500, 2000, 2500, and 3000 mW, while the exposure time was kept constant at 2000 ms. The burn effect of the G-probe was then assessed at different time settings of 1000, 1500, 2000, 2500, and 3000 ms, while the power output was kept constant at 2000 mW. The grey scale sheets were then analysed for the burns produced, as described earlier, and the results for each time/power setting where the total energy value was similar were compared (eg 1000 mW/2000 ms setting was compared to the 1000 ms/ 2000 mW setting, ie total energy value 2 J).
Comparison of laser burns produced by new and old probes A new G-probe was assessed using the protocol given in the pilot study (under the heading 'determining 'threshold burns' at 'standard settings' ', ie 2000 ms/ 2000 mW). The laser burns produced were compared to an old probe, which had been used in six previous sessions of cyclodiode therapy.
Statistics The results from the five new probes were analysed using statistical tests. Burn scores and burn sizes were assessed using the Mann-Whitney rank test. A one-way ANOVA was used to compare the burn sizes recorded on grey shades 8 and 9. Data from the time and power variation part of the study were analysed by a paired t-test, a P-value of o0.05 was taken as statistically significant.
Results

Results of Study A: questionnaire-based survey of ophthalmologists
Of the 71 ophthalmologists to whom a questionnaire was sent, 44 replied (62% response rate). Of the respondents, 88.6% (41 ophthalmologists) used the G-probe to perform cycloablative therapy and 58.5% of these clinicians reused the probe. Tables 1 and 2 summarise the results of the questionnaire.
Results of Study B: a pilot study to develop a 'grey scale test' 'Burn score', 'threshold burn' and 'threshold' Following the pilot study, it was found that using 'standard settings' (2000 ms and 2000 mW), three consistent burns (burn size greater than 1500 mm) could be produced on grey shade 8 ( Figure 2d ). At lighter grey shades, consistent burns could not be produced using these 'standard settings'. From this initial study, we defined the terms 'threshold burn' and 'threshold grey shade'. A 'threshold burn' was defined as a visible burn in excess of 1500 mm in size and, when all three laser shots produced 'threshold burns' on a particular grey shade, then this grey shade value was taken as the 'threshold grey shade'.
Reproducibility and interoperator variability of the method Using five new probes at 'standard settings', no significant difference was found in the burn size when each of the five new probes (Figure 3a ) was tested on grey shade 8. When burns were produced on grey shade 9, burn sizes were found to be significantly larger on grey shade 9 than on grey shade 8 (Po0.001, one-way ANOVA) (Figure 3a) . Using five different grey scale sheets (printed on different batches of paper) and two different operators, threshold burns were produced consistently on grey shade 8. No interoperator, intraoperator, or intersheet differences were found (Figure 3b ).
Minimum power setting to produce a 'threshold burn' Figure 4a shows the burn sizes produced by the five new probes (on grey scale 8), with power settings ranging from 1000 to 2100 mW but keeping the laser time exposure constant at 2000 ms. Above 1800 mW, all the probes produced consistent 'threshold burns'; however, below 1700 mW the burns produced were less consistent. Figure 4a also shows that the testing system could detect statistically significant changes (Po0.05) in burn diameter when the laser power setting was increased by 20% or more above 1500 mW.
Results of Study C: using the 'grey scale test' to assess the output of the G-probe using different laser settings Assessing changing laser output parameters Figure 4b shows the effect of changing exposure time while keeping the laser power setting at 2000 mW. The graph shows that the threshold burns on grey shade 8 can be produced on grey shade 7 if the laser exposure time is increased to 3000 ms. Figure 4b also shows that increasing the laser exposure time also increases the diameter of the burns produced. Figure 4c shows the effect of different laser power settings while keeping the laser exposure time constant at 2000 ms. Threshold burns can be achieved at lighter grey shades if the power setting is set above 2500 mW, and a power setting of 3000 mW can produce threshold burns at grey shade 5. Figure 4c also shows that larger burn diameters are produced with higher laser powers.
Comparing the effect of changing power settings with time settings for a given laser output Using a paired t-test, the effects of changing power and time settings for a given total energy output were compared (Table 3a and b), and the burn sizes for each energy level are compared with differing time and power settings, in Figure 5a . When total energy levels were greater than 4 J, altering the power setting had a greater effect in producing larger burns than by increasing the time setting, even though the overall energy output was the same.
Assessing the output of a 'new' probe with an 'old' probe A new G-probe produced nonthreshold burns at grey shade 7 and produced threshold burns on grey shade 8. Using the old probe, threshold burns were only produced on grey density 9 (Figure 5b) . The new probe also produced larger burns compared to an old probe at any given grey shade (Figure 5b) . 
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Discussion
Cyclodiode therapy using the G-probe and diode laser is proving to be a popular and effective form of therapy to treat intractable high intraocular pressure. 2, [3] [4] [5] [6] [7] [8] [9] 14, 15 It is recommended that the G-probe is used for a single treatment session and reuse is not advised. 11 However, it is clear from this study that many clinicians in the UK reuse probes. This study found that those clinicians who performed cyclodiode therapy on a weekly basis were reusing probe the most (69% of clinician performing weekly cyclodiode therapy reuse probes). It is likely that probes become less effective with reuse, resulting in reduced efficacy of the laser treatment; thus, for clinicians who reuse probes, it is important that there is a method to assess the output of the G-probe before use.
The method advised by the manufacturers of Oculight SLx Diode Laser (Iris Medical Instruments Inc., Mountain View, CA, USA) to measure the output of G-probe is to use a calibrated laser power meter. The technique involves immersing the G-probe tip in a glass Petri dish filled with deionised water (to prevent the scattering of light at the probe tip). The calibrated laser power meter is then positioned underneath the dish so that emitted laser light can be measured. Calculations are then required to compensate for expected losses as a 
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Assessing the 'cyclodiode G-probe' using a grey scale test P Hossain et al result of reflections at the glass/air interface. Although this test will provide an absolute value for the probe output, this type of assessment is not practical in the clinical setting and therefore a more practical method is required. The method described in this paper is simple to perform, does not demand special calculations to be performed, or require special skills by the operator. The reproducibility is indicated by consistency of the results with different operators, different batches of grey scale sheets, and different batches of new probes. The data also show that this testing system can reliably detect changes in probe output of 20% or more when the laser is set above 1500 mW.
The G-probe is designed to create a burn near the probe tip when applied to the conjunctiva and sclera, whereas in the testing system the probe is in contact with air where the emitted light will then diverge from the probe tip and then be absorbed on the grey scale. Although there is a distinct difference between the testing system and that of clinical use, the results do show that increasing burn size is associated with increasing laser output. The correlation of increasing burn size to the output provides validity to this method despite the fact that the absolute output at the probe tip has not been measured. Thus, the method indicates, in a semiquantitative way, the G-probe output by its ability to produce a burn on a test sheet.
Surprisingly, the study also shows that the effectiveness of the laser, using our testing system, varies more with changes to the power setting than changes to the time setting when the total energy output is greater than 4 J. A 'threshold' burn is more likely to occur at a higher power setting than higher time setting, even when the total energy delivered is the same. This discrepancy may be because of the low thermal conductivity paper, allowing less dissipation of heat in a short time period, with the resulting effect that high powers at short time periods are more likely to cause burns than vice versa.
The results also show that 'threshold' burns are more likely to be produced with higher grey densities indicating that the amount of visible ciliary body pigmentation may be significant in determining the degree of ciliary body ablation that is produced following cyclodiode therapy.
Additionally, the results show that a reused probe is less effective at 2000 mW and 2000 ms in producing threshold burn on the threshold grey scale of 8 than a new probe. As indicated in the case of a reused probe (six previous uses), the output of the probe is reduced. However, the results of this study also indicate that by adjusting the laser setting, 'threshold burns' may be produced by the probe in question.
Since we have found that a G-probe using diode laser settings of 2000 mW and 2000 ms produces burns (approximately 1700 mm) on grey scale 8, we suggest that those clinicians reusing probes use this test prior to commencement of a cyclodiode therapy. The G-probe can be tested using the chart as shown in Figure 2d , the test burns can then be compared to the scale given in the legend on the chart (the chart includes a series of dots of different sizes and the 1700 mm size is indicated by an arrow). When a burn on the grey scale has reached the standard size of burn produced for 'standard settings' (ie burn size of 1700 mm or more), then the G-probe is 'calibrated' and is ready for use on the patient. Any change in threshold value can then be compensated by appropriate changes to the time and power settings so that a probe produces threshold burns on scale 8. Such adjustments may therefore be useful to 'compensate' for the loss of laser output experienced with repeated use of the probe. The system may also be used to test the efficacy of new probes to ensure that damage to the probe has not occurred in transit.
Although the effect of laser ciliary body ablation is dependent on many variable factors such as ciliary body pigmentation or scleral thickness, 13 standardisation of the treatment protocol has been shown to lead to a pressure lowering effect with relatively few complications. 6 Hence, the prior testing of the G-probe in hospitals where clinicians are reusing probes, is another step that may lead to a 'standard' response following therapy.
In summary, this study shows that the practice of reuse of G-probes by ophthalmologists who perform cyclodiode therapy is widespread. This study demonstrates a practical test that can be used by those clinicians who reuse probes. The simplicity of the method means that the test can be performed without sophisticated equipment and with ease in the clinical setting. This strategy for probe assessment may lead to a more reliable amount of ciliary body ablation and to a more predictable intraocular pressure reduction following treatment.
